Creating realistic models to improve cancer treatment imaging
Validation and dissemination of novel physical phantoms for quantitative theranostics research
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-11160228
This study is creating realistic 3D-printed models of human anatomy to help doctors get better images and measurements during cancer treatments, making sure that sensitive organs are protected and improving care for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11160228 on ClinicalTrials.gov |
What this research studies
This research focuses on developing and validating realistic 3D-printed phantoms that accurately represent human anatomy to enhance quantitative imaging for radiopharmaceutical therapies (RPTs) used in cancer treatment. By using patient scans to create these models, the project aims to improve the accuracy of dose measurements in sensitive organs during imaging procedures. The phantoms will be tested across multiple imaging technologies and clinical settings to ensure their effectiveness and reliability. This innovative approach seeks to address current limitations in existing phantoms, ultimately benefiting patient care in cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing radiopharmaceutical therapies for various cancers.
Not a fit: Patients not receiving radiopharmaceutical therapies or those with conditions unrelated to cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate imaging techniques that improve the effectiveness of cancer treatments.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques and phantoms, indicating that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JHA, ABHINAV K — WASHINGTON UNIVERSITY
- Study coordinator: JHA, ABHINAV K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.